• Follow Us On : 

Jacobson Pharma Issues Positive Profit Alert


Redaksi | Jumat,03 Mei 2019 - 02:55:23 WIB
Dibaca: 1346 kali 
Jacobson Pharma Issues Positive Profit Alert

Expects to Record Over 20% Increase in Profit Attributable to Shareholders

CHINA - 2 May 2019 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the  "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert. Based on a preliminary review on the unaudited consolidated management accounts of the Group for the financial year ended 31 March 2019, the Group is expected to record an increase of over 20% in the consolidated profit attributable to shareholders of the Company as compared with that for the financial year ended 31 March 2018.

The encouraging results were mainly attributable to a steady growth of generic drug business along with the sales revenue generated from newly in-licensed products coupled with an uplifted sales performance on proprietary medicines. Operating leverages and financial savings derived from cost control measures, as well as fair value gain on investment properties of the Group are also expected to contribute to the above-mentioned increase.

Embedding the strategies of regional expansion and targeted portfolio enhancement through in-licensing or products developed in-house, Jacobson Pharma aims to become a leading generic drug and proprietary medicine company in Asia by building a commercially competitive platform in the region.

Backed by a vertically-integrated supply chain and its efficient production facilities as well as a robust in-house research and development pipeline, the Group is among the few with the most extensive sales and distribution coverage in both the private and public sectors in Hong Kong and is poised for a broadened geographic footprint.

Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, said, "The expected increase in earnings of the Company reflects the effectiveness of our across-the-board efforts and demonstrates our capabilities to execute on our growth strategies. From expanding our product portfolios to optimizing the  operating leverage across our production facilities as well as  implementing effective cost controls, our holistic and prudent approach is aimed at facilitating the Group's long-term growth and creating value for our shareholders."


Akses Wahanariau.com Via Mobile m.Wahanariau.com
Untuk Berbagi Berita / Informasi / Peristiwa
Silahkan SMS ke nomor HP : 085271472010
atau email ke alamat : [email protected]
Harap camtumkan detail data diri Anda
Pengutipan Berita dan Foto, Cantumkan Wahanariau.com Sebagai Sumber Tanpa Penyingkatan
TULIS KOMENTAR
BERITA TERKAIT
Rabu,23 September 2020

Jacobson Pharma Submits Form A1 to Spin-off Its Branded Healthcare Business

CHINA - Media OutReach - 23 September 2020 - Jacobson Pharma Corporation Limited ("Jacobson Pha

Kamis,31 Oktober 2019

Jacobson Pharma Forms Joint Venture with Kin Fung Weisen-U

Expands Branded Product Portfolio and Develops New Markets for Gastrointestinal and Respiratory Prod

Jumat,15 Januari 2021

Jacobson Pharmas Proposed Spin-off and Separate Listing of JBM Limited on The Main Board of The Stock Exchange of Hong Kong Limited

Declaration of Conditional Special Interim Dividend HONG KONG SAR - 15 January 2021 - Jacobson Phar

Selasa,30 Juni 2020

Jacobson Pharma Announces FY2020 Annual Results

Delivers Solid Performance Amidst Market Challenges Revenue Increases +6.3% Maintains Full-Year Divi

Kamis,27 Agustus 2020

Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SEs COVID-19 Vaccine Candidate in Hong Kong and Macau

CHINA - Media OutReach - 27 August 2020 - Jacobson Pharma Corporation Limited ("Jacobson Pharma

Kamis,22 November 2018

Jacobson Pharma Announces FY2019 Interim Results

Profit from Operations Leapt by 40.7% to HK$158.6 Million Declares Interim Dividend of HK1

BERITA LAINNYA
Kamis,02 Februari 2023

Carousell Group Integrates Laku6 Team, AI-first Diagnostics Technology to Drive Mobile Recommerce Expansion Across Greater Southeast Asia

SINGAPORE - 2 February 2023 - Harnessing the scale of two million listings listed in the electronics

Kamis,02 Februari 2023

Asian Stationery & Office Products Online Exhibition 2023 Grand Opening

TAIPEI - 2 February 2023 - Asian Stationery & Office Products Online Exhibition (ASOP 2023) is a

Kamis,02 Februari 2023

ThreatLocker® Unveils the Future of Zero Trust with New Products

Global Cybersecurity leader unifies critical components of their stack with new Ops and other featur

BERGABUNG DI SINI
KABAR POPULER
IKUTI BERITA KAMI